查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1827850

植入式医疗设备市场（按产品类型、材料、应用和最终用户划分）—2025-2032 年全球预测

Implantable Medical Device Market by Product Type, Material, Application, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，植入式医疗设备市场规模将成长至 1,465.6 亿美元，复合年增长率为 7.36%。

主要市场统计数据
基准年2024年 829.9亿美元
预计2025年 887.8亿美元
预测年份：2032年 1465.6亿美元
复合年增长率（%） 7.36%

一份全面的策略介绍，概述了意图、范围、相关人员的优先事项和关键主题，以指南有关植入式设备的业务决策

本执行摘要以结构化、主导的观点，探讨植入式医疗设备领域，旨在为董事会层面的策略制定、产品开发重点和公司规划提供参考。摘要概述了影响决策的关键主题：技术整合、监管复杂性、采购动态和不断发展的临床路径，并强调了创新与实际部署挑战之间的相互关係。引言部分旨在帮助读者熟悉报告的分析方法，明确主要读者，并概述如何利用研究结果来支持近期专案选择和长期投资组合合理化。

导言部分透过提出清晰的问题并明确所要应对的策略挑战，建立了通用的解读基准。本书重点阐述了临床结果、供应链结构和报销环境将如何决定植入式器械的采用轨迹。因此，读者将获得精准的指导，将技术性能和材料选择与机构采购行为和临床医生的接受度联繫起来，从而能够在临床、监管和商业职能部门进行更有针对性的后续跟进。

快速变化和技术采用动态塑造植入式医疗创新的临床、监管方法和供应链弹性

在技​​术创新、监管审查力度加大以及临床医生期望不断变化等因素的推动下，植入式医疗设备的格局正在迅速变化。先进材料和微型电子设备正在催生出集感测、驱动和连接功能于一体的新型设备，而影像处理和外科技术的进步则正在拓展可能的干预范围。同时，监管机构也日益重视上市后监管、网路安全要求和人为因素检验，凸显了强而有力的临床证据和生命週期管理的重要性。

供应链动态正朝着更具弹性和地理多样性的方向转变，这迫使製造商重新思考筹资策略，并加强与委託製造製造商和专业供应商的合作。付款方和供应商生态系统要求更强有力的价值证明和以患者为中心的成果，这正在影响产品设计和商业化计划。这些转变的整合意味着公司必须比以往任何时候都更加紧密地协调其研发、监管和市场进入职能，并采用更敏捷的营运模式，将技术进步转化为持续的临床应用和永续的商业性回报。

评估2025年美国关税对製造业、筹资策略、跨国合作及医疗设备供应链的累积影响

2025年影响跨境贸易和关税制度的政策变化将对植入式设备製造商、供应商和采购商产生重大影响。关税调整正在改变全球供应链的成本结构，迫使采购团队重新评估采购区域，并评估近岸外包和区域采购作为传统集中模式的替代方案。这些决策将影响供应商谈判、库存策略，以及在投资本地製造能力和维护全球供应商关係之间的平衡。

因此，企业正在重新审视其总到岸成本分析和供应商风险状况，以了解其对产品供应和生产前置作业时间的累积影响。临床服务提供者也正在重新审视竞标週期和设备选择标准，以降低价格波动和潜在中断带来的风险。除了直接的营运变化外，关税主导的转变还促使製造商和医疗系统之间进行策略合作，包括签订多年期合约和联合规划产能缓衝。透过这些因应措施，相关人员旨在维持临床的连续性，同时使商业模式适应更复杂的国际贸易环境。

关键细分洞察揭示了医疗保健服务环境中产品、材料组合、临床应用和最终用户设定的需求模式差异

市场区隔洞察揭示了产品类型、材料、应用和最终用户环境的需求概况和开发优先级，从而为产品组合和上市策略提供资讯。产品层面的差异化非常重要。心臟植入（如去心房颤动和心律调节器）需要强调严格可靠性、长期远端检测、耐用性和远端监控的监管途径。乳房植入和脸部植入等美容植入优先考虑生物相容性材料和美学效果，这取决于患者的偏好和外科医生的技术。牙科植入直接与修復工作流程交互，需要精确的材料和表面工程来增强骨整合。神经植入需要超低延迟电子设备和密封包装来支援精细的神经应用。眼科植入必须符合微尺度公差和眼科安全标准。材料细分（陶瓷、金属和聚合物）决定了耐磨性、耐腐蚀性、影像相容性和组织反应方面的性能权衡，从而影响设备选择和临床通讯协定。基于应用（例如心臟病学、整形外科、牙科、神经内科、整形外科）的细分，进一步指导了临床证据的开发和报销定位。最终使用者（门诊手术中心、诊所和医院）拥有不同的采购週期、手术量和资金约束，这些因素决定了他们的采购管道和服务支援需求。整合这些细分视角，可以更精细地确定产品与市场的契合度、确定临床试验的优先级，并客製化反映每个医疗环境营运现状的商业模式。

战略区域洞察，重点关注美洲、欧洲、中东和非洲以及亚太市场的需求驱动因素、监管细节和采用障碍

区域差异持续对植入式器械的监管流程、报销途径和实施时间表产生重大影响。美洲市场拥有成熟的临床生态系统、完善的报销框架和较高的手术量，对能够展现明确临床和经济价值的高端医疗设备极具吸引力。相较之下，欧洲、中东和非洲的监管格局则呈现出差异化，区域协调倡议和国家特定的报销流程并存，这既为差异化的参与策略创造了机会，也带来了证据一致性方面的挑战。亚太地区基础设施扩张迅速，训练有素的专家数量不断增加，政府主导的医疗能力提升倡议也为新外科技术的快速应用提供了支持，儘管价格敏感度较高，且监管时间表各不相同。

这些区域动态对监管申报、上市后预期和商业性优先排序具有实际意义。公司通常会根据报销准备和临床领军人才的可用性来安排上市顺序，同时根据区域采购标准客製化通讯和定价策略。策略性区域伙伴关係和适应性上市策略对于平衡全球产品标准化与本地客製化需求至关重要，从而实现扩充性且有效的区域推广计画。

竞争对手层面的洞察，重点在于领先设备製造商的策略组合、合作伙伴网路、智慧财产权重点和营运重点

植入式器械生态系统中的主要企业透过专注于生命週期管理和临床证据产生的策略性投资组合选择、合作伙伴关係和业务投资，脱颖而出。一些製造商正在深化其在相关服务产品方面的能力，例如远端监控平台、上市后监测数据分析以及外科医生培训解决方案，以提供能够改善患者预后并巩固临床工作流程的整合提案。其他公司则专注于核心器械性能和卓越製造，投资于品质系统和先进材料工程，以确保临床信心并降低再手术率。

竞争态势也揭示了不同的智慧财产权和合作模式。与学术中心和科技公司的合作加速了创新週期，而选择性收购则填补了电子、生物材料和软体方面的能力缺口。优先事项还包括可製造的模组化设计、检验供应链中的可追溯性，以及建立监管路径，以应对更严格的网路安全和人为因素标准。对于决策者而言，竞争优势显然将源于技术差异化、整合服务模式以及透过严谨的证据和上市后追踪证明持续临床价值的能力的结合。

为行业领导者提供切实可行的业务建议，以加速创新、优化供应链、加强合规性并快速改善以患者为中心的结果

行业领导者应优先考虑一系列切实可行的行动，以应对当前的挑战并抓住新的机会。首先，协调研发和临床证据项目，提供与临床医生和付款人产生共鸣的结果指标，确保设计选择能够预测实际使用情况和报销标准。其次，透过多元化供应商、确定区域生产合作伙伴以及实施库存缓衝策略来增强供应链的弹性，以减轻关税和物流衝击。第三，投资可互通的数位平台和安全遥测技术，以增强设备的价值提案，并满足人们对远端监控和网路安全日益增长的期望。

此外，我们正在透过试验计画、外科医生培训和风险分担安排深化与医疗服务提供者网路的合作，以加速应用并产生可操作的真实世界数据。我们正在修订定价和合约策略，以反映护理总成本和长期疗效效益，而不仅仅是单位成本。最后，我们正在将监管策略整合到早期设计决策中，以缩短核准时间并简化上市后义务。共同实施这些建议将打造一条从创新到部署的一致路径，在速度、合规性和临床影响之间取得平衡。

严谨的调查方法，阐明资料来源、相关人员参与、定性和定量检验步骤以及分析框架

本报告背后的调查方法结合了系统性证据收集、相关人员参与和交叉检验，以确保研究结果可靠且可操作。主要资讯包括对临床医生、采购负责人和技术专家的结构化访谈，以及手术现场访问，以观察工作流程互动和器械操作注意事项。次要资讯包括同行评审的临床文献、监管指导文件和技术标准，这些资料为材料性能、安全注意事项和生命週期管理实践的评估提供了参考。

分析步骤将定性洞察与针对特定设备和应用的技术评估相结合，以识别关键成功因素和应用障碍。检验透过相关人员观点以及与包含独立临床顾问的审查委员会的三角检验进行。自始至终，我们高度重视资料来源、调查方法和资料来源的透明度以及利益衝突的揭露，从而巩固了结论的可信度。这种多层次的方法确保了建议既基于临床现实，又基于技术可行性，从而能够切实转化为策略倡议。

简明结论综合了战略意义、新兴风险载体以及临床、製造和政策领域相关人员的优先行动

结论部分总结了参与植入式器械开发、商业化和采购的利害关係人的策略重点。虽然新技术和材料科学的进步拓展了临床应用的可能性，但从创新到持续应用的道路取决于整合策略，该策略将临床证据、监管预见性和供应链稳健性相结合。相关人员必须在上市速度与全面的风险管理之间取得平衡，尤其是网路安全、上市后监管和人为因素。

务实而言，整合产品设计、临床参与和商业性规划的组织将更有能力确保产品的持久应用，并为患者带来可衡量的益处。报告强调了区域战略、有针对性的细分市场和合作伙伴关係关係对于克服成本压力和政策主导的复杂性的重要性。透过将这些策略洞察转化为优先行动计划，领导者可以抓住机会，减少实施阻力，并改善临床环境中的疗效。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

  • 由于可生物降解和可生物吸收植入物的普及，修復手术减少
  • 在起搏器和神经刺激设备中整合无线连接和远端监控
  • 微型化的进步使得微创心臟和神经植入成为可能
  • 下一代MRI相容植入整形外科器械获得监管部门核准，扩大患者使用范围
  • 利用人工智慧演算法个人化调整深部脑刺激参数
  • 封闭回路型连续血糖监测智慧胰岛素帮浦的研製
  • 植入采用抗菌奈米技术涂层，以降低术后感染的风险

第六章：2025年美国关税的累积影响

第七章：人工智慧的累积影响，2025年

第八章植入式医疗设备市场（依产品类型）

  • 心臟植入
    • 去心房颤动
    • 起搏器
  • 美容植入
    • 乳房植入
    • 脸部植入
  • 人工植牙
  • 神经植入
  • 眼科植入
  • 整形外科植入
    • 髋关节植入
    • 膝关节植入

第九章植入式医疗设备市场（依材料）

  • 陶瓷製品
  • 金属
  • 聚合物

第 10 章植入式医疗设备市场（依应用）

  • 心臟病学
  • 整容手术
  • 牙科
  • 神经病学
  • 整形外科

第 11 章植入式医疗设备市场（依最终用户）

  • 门诊手术中心
  • 诊所
  • 医院

第十二章植入式医疗设备市场（按地区）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章植入式医疗设备市场（依类别）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章植入式医疗设备市场（依国家）

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章竞争格局

  • 2024年市占率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • 3M Company
    • Abbott Laboratories
    • Aleva Neurotherapeutics
    • Allergan Inc. by AbbVie Inc.
    • B. Braun Melsungen AG
    • BIOTRONIK SE & Co KG
    • Boston Scientific Corporation
    • Cochlear Ltd.
    • Conmed Corporation
    • Definitive Healthcare, LLC
    • Demant A/S
    • Dentsply Sirona Inc.
    • Edwards Lifesciences Corporation
    • Globus Medical, Inc.
    • Integra Lifesciences Holdings Corporation
    • Invibio Ltd.
    • Johnson & Johnson Services, Inc.
    • Koninklijke Philips NV
    • LivaNova plc
    • Medtronic PLC
    • Microport Scientific Corporation
    • NuVasive, Inc.
    • Smith & Nephew PLC
    • Sonova Holding AG
    • Sterling Medical Devices
    • Straumann AG
    • Stryker Corporation
    • Terumo Corporation
    • WL Gore & Associates, Inc.
    • Zhejiang Nuoerkang Neuroelectronic Technology Co., Ltd.
    • Zimmer Biomet Holdings, Inc.
Product Code: MRR-4355714631BF

The Implantable Medical Device Market is projected to grow by USD 146.56 billion at a CAGR of 7.36% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 82.99 billion
Estimated Year [2025] USD 88.78 billion
Forecast Year [2032] USD 146.56 billion
CAGR (%) 7.36%

Comprehensive strategic introduction that frames the intent, scope, stakeholder priorities, and major themes guiding executive decisions in implantable devices

This executive summary introduces a structured, evidence-driven perspective on the implantable medical device arena, intended to inform board-level strategy, product development priorities, and operational planning. It frames the principal themes that influence decision-making-technology convergence, regulatory complexity, procurement dynamics, and evolving clinical pathways-while highlighting the interplay between innovation and practical deployment challenges. The introduction situates readers to the report's analytical approach, clarifies intended audiences, and outlines how insights can be mobilized to support near-term program choices and longer-term portfolio rationalization.

By establishing a clear problem statement and defining the strategic questions addressed, the introduction creates a common baseline for interpretation. It emphasizes how clinical outcomes, supply chain structure, and reimbursement environments jointly determine adoption trajectories for implantable devices. Consequently, readers gain a precise orientation that links technical performance and material selection to institutional purchasing behavior and clinician acceptance, enabling more targeted follow-through across clinical, regulatory, and commercial functions.

Rapid transformative shifts and technology adoption dynamics reshaping clinical practice, regulatory approaches, and supply chain resilience across implantable medical innovations

The landscape for implantable devices is undergoing rapid transformation driven by technological innovation, intensified regulatory scrutiny, and evolving clinician expectations. Advanced materials and miniaturized electronics are enabling new classes of devices that blend sensing, actuation, and connectivity, while concurrent progress in imaging and surgical techniques is expanding the range of feasible interventions. At the same time, regulators are increasing emphasis on post-market surveillance, cyber-security requirements, and human factors validation, which elevates the importance of robust clinical evidence and lifecycle management.

Supply chain dynamics have shifted toward resilience and geographic diversification, prompting manufacturers to reconsider sourcing strategies and increase collaboration with contract manufacturers and specialized suppliers. Payer and provider ecosystems are demanding stronger proof of value and patient-centered outcomes, which in turn influences product design and commercialization plans. These converging shifts mean that companies must align R&D, regulatory, and market access functions more tightly than before, and they must adopt more agile operational models to translate technical advances into durable clinical adoption and sustainable commercial returns.

Assessment of the cumulative implications of United States tariff measures in 2025 on manufacturing, procurement strategies, cross-border collaboration, and device availability

Policy changes affecting cross-border trade and tariff regimes in 2025 have generated material implications for manufacturers, suppliers, and purchasers of implantable devices. Tariff adjustments have altered cost structures across global supply chains, prompting procurement teams to reassess sourcing geographies and to evaluate nearshoring or regional sourcing as alternatives to previously centralized models. These decisions affect supplier negotiations, inventory strategies, and the calculus for investing in local production capability versus maintaining global supplier relationships.

Consequently, companies are revisiting total landed cost analyses and supplier risk profiles to understand the cumulative impact on product availability and production lead times. Clinical providers are also reassessing tender cycles and device selection criteria to mitigate exposure to price volatility and potential disruptions. Beyond immediate operational changes, tariff-driven shifts are encouraging more strategic collaboration between manufacturers and health systems, including multi-year agreements and joint planning for capacity buffers. Through these responses, stakeholders aim to preserve clinical continuity while adapting commercial models to a more complex international trade environment.

Key segmentation insights that reveal differential demand patterns by product, material composition, clinical application, and end-user settings across care delivery environments

Segmentation insights reveal distinct demand profiles and development priorities across product types, materials, applications, and end-user settings that inform portfolio and go-to-market strategies. Product-level differentiation is pronounced: cardiac implants such as defibrillators and pacemakers require stringent reliability, long-term telemetry, and regulatory pathways that emphasize durability and remote monitoring; cosmetic implants including breast and facial implants prioritize biocompatible materials and aesthetic outcomes driven by patient preference and surgeon technique; dental implants interface directly with restorative workflows and demand precision materials and surface engineering to enhance osseointegration; neural implants require ultra-low latency electronics and hermetic packaging to support sensitive neurologic applications; ophthalmic implants must satisfy micro-scale tolerances and ophthalmologic safety standards; and orthopedic implants including hip and knee implants focus on load-bearing materials and proven surgical instrumentation. Materials segmentation-ceramic, metal, and polymer-shapes performance trade-offs for wear, corrosion resistance, imaging compatibility, and tissue response, influencing both device selection and clinical protocols. Application-based segmentation across cardiology, cosmetic procedures, dentistry, neurology, and orthopedics further guides clinical evidence development and reimbursement positioning because each application area presents unique outcome metrics and adoption pathways. End users-ambulatory surgical centers, clinics, and hospitals-exhibit differing procurement cycles, procedural volumes, and capital constraints, which together determine purchasing levers and service-support needs. Integrating these segmentation lenses enables more granular product-market fit decisions, prioritization of clinical trials, and tailored commercial models that reflect the operational realities of each care environment.

Strategic regional insights focusing on demand drivers, regulatory nuances, and adoption barriers across the Americas, Europe Middle East & Africa, and Asia-Pacific markets

Regional differences continue to exert substantial influence on regulatory processes, reimbursement pathways, and adoption timelines for implantable devices. The Americas market combines a mature clinical ecosystem with established reimbursement frameworks and high procedural volumes, making it attractive for premium devices that can demonstrate clear clinical and economic value. In contrast, Europe, Middle East & Africa presents a heterogeneous regulatory landscape where regional harmonization initiatives coexist with country-specific reimbursement processes, creating both opportunities for differentiated entry strategies and challenges in evidentiary alignment. Asia-Pacific demonstrates rapid infrastructure expansion, an increasing number of trained specialists, and government-led initiatives to upgrade healthcare capacity, which together support faster uptake of new surgical technologies, albeit with greater price sensitivity and variable regulatory timetables.

These regional dynamics have practical implications for regulatory submissions, post-market surveillance expectations, and commercial prioritization. Companies often sequence launches to align with reimbursement readiness and clinical champion availability, while tailoring messaging and pricing strategies to local procurement norms. Strategic regional partnerships and adaptive market access approaches are essential to balance global product standardization with local customization needs, enabling scalable yet regionally effective deployment plans.

Competitive company-level insights highlighting strategic portfolios, collaboration networks, intellectual property focus, and operational priorities among leading device manufacturers

Leading companies in the implantable device ecosystem are differentiating through strategic portfolio choices, alliances, and operational investments that emphasize lifecycle management and clinical evidence generation. Some manufacturers are deepening capabilities in adjacent service offerings-such as remote monitoring platforms, data analytics for post-market surveillance, and surgeon training solutions-to create integrated propositions that improve patient outcomes and lock in clinical workflows. Others concentrate on core device performance and manufacturing excellence, investing in quality systems and advanced materials engineering to secure clinical trust and reduce revision rates.

Competitive dynamics also reveal varied approaches to intellectual property and collaborative models: partnerships with academic centers and technology firms accelerate innovation cycles, while selective acquisitions fill capability gaps in electronics, biomaterials, or software. Operational priorities include modular design for manufacturability, validation of supply chain traceability, and building regulatory pathways that anticipate tightening standards for cybersecurity and human factors. For decision-makers, the implication is clear: competitive advantage now stems from a blend of technical differentiation, integrated service models, and the ability to demonstrate sustained clinical value through rigorous evidence and post-market follow-up.

Actionable, operational recommendations for industry leaders to accelerate innovation, optimize supply chains, strengthen compliance, and enhance patient-centric outcomes rapidly

Industry leaders should prioritize a set of pragmatic, executable actions to navigate current headwinds while capturing emerging opportunities. First, align R&D and clinical evidence programs to deliver outcome measures that resonate with both clinicians and payers, ensuring that design choices anticipate real-world use conditions and reimbursement criteria. Second, strengthen supply chain resilience by diversifying suppliers, qualifying regional production partners, and implementing inventory-buffer strategies that mitigate tariff and logistics shocks. Third, invest in interoperable digital platforms and secure telemetry to enhance device value propositions and meet rising expectations for remote monitoring and cybersecurity.

Additionally, foster deeper collaboration with provider networks through pilot programs, surgeon training, and shared risk arrangements that accelerate adoption and generate practical real-world data. Reassess pricing and contracting strategies to reflect total cost of care and long-term outcome benefits rather than unit price alone. Finally, integrate regulatory strategy into early-stage design decisions to reduce time to approval and simplify post-market obligations. Executed together, these recommendations create a cohesive pathway from innovation to deployment that balances speed, compliance, and clinical impact.

Rigorous research methodology delineating data sourcing, stakeholder engagement, qualitative and quantitative validation steps, and analytical frameworks

The research methodology underpinning this report combines systematic evidence collection, stakeholder engagement, and cross-validation to ensure robust, actionable findings. Primary inputs included structured interviews with clinicians, procurement leaders, and technical experts, alongside site visits to procedural settings to observe workflow interactions and device handling considerations. Secondary inputs comprised peer-reviewed clinical literature, regulatory guidance documents, and technical standards that informed assessment of material performance, safety considerations, and lifecycle management practices.

Analytical steps involved synthesis of qualitative insights with device- and application-specific technical assessments to identify critical success factors and adoption barriers. Validation occurred through triangulation of stakeholder perspectives and review panels with independent clinical advisors. Throughout, an emphasis on transparency in data sources, methodological assumptions, and conflict-of-interest disclosures supports the credibility of conclusions. This layered methodology ensures that recommendations are grounded in both clinical reality and technical feasibility, enabling pragmatic translation into strategic initiatives.

Concise conclusion synthesizing strategic implications, emergent risk vectors, and priority actions for stakeholders across clinical, manufacturing, and policy domains

The concluding synthesis draws together strategic imperatives for stakeholders engaged in implantable device development, commercialization, and procurement. Emerging technologies and material science advances expand clinical possibilities, but the pathway from innovation to sustained adoption depends on integrated strategies that combine clinical evidence, regulatory foresight, and supply chain robustness. Stakeholders must balance speed-to-market with comprehensive risk management-particularly in areas such as cybersecurity, post-market surveillance, and human factors-because these domains increasingly govern regulatory acceptability and clinician confidence.

In practical terms, organizations that unify product design, clinical engagement, and commercial planning will be better positioned to secure durable adoption and deliver measurable patient benefits. The report underscores the importance of regional strategy, targeted segmentation, and collaborative partnerships to overcome cost pressures and policy-driven complexities. By translating these strategic insights into prioritized action plans, leaders can reduce implementation friction and seize opportunities to improve outcomes across clinical settings.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Rising adoption of biodegradable and bioresorbable implantable devices reducing revision surgeries
  • 5.2. Integration of wireless connectivity and remote monitoring in pacemakers and neurostimulators
  • 5.3. Advancements in miniaturization enabling minimally invasive cardiac and neural implants
  • 5.4. Regulatory approval of next-generation MRI-safe implantable orthopedic devices expanding patient access
  • 5.5. Use of artificial intelligence algorithms for personalized adjustment of deep brain stimulation parameters
  • 5.6. Development of smart insulin pumps with closed loop continuous glucose monitoring functionality
  • 5.7. Adoption of antimicrobial nanotechnology coatings on implants to reduce post operative infection risks

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Implantable Medical Device Market, by Product Type

  • 8.1. Cardiac Implants
    • 8.1.1. Defibrillator
    • 8.1.2. Pacemaker
  • 8.2. Cosmetic Implants
    • 8.2.1. Breast Implants
    • 8.2.2. Facial Implants
  • 8.3. Dental Implants
  • 8.4. Neural Implants
  • 8.5. Ophthalmic Implants
  • 8.6. Orthopedic Implants
    • 8.6.1. Hip Implants
    • 8.6.2. Knee Implants

9. Implantable Medical Device Market, by Material

  • 9.1. Ceramic
  • 9.2. Metal
  • 9.3. Polymer

10. Implantable Medical Device Market, by Application

  • 10.1. Cardiology
  • 10.2. Cosmetic Procedures
  • 10.3. Dentistry
  • 10.4. Neurology
  • 10.5. Orthopedics

11. Implantable Medical Device Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Clinics
  • 11.3. Hospitals

12. Implantable Medical Device Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Implantable Medical Device Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Implantable Medical Device Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. 3M Company
    • 15.3.2. Abbott Laboratories
    • 15.3.3. Aleva Neurotherapeutics
    • 15.3.4. Allergan Inc. by AbbVie Inc.
    • 15.3.5. B. Braun Melsungen AG
    • 15.3.6. BIOTRONIK SE & Co KG
    • 15.3.7. Boston Scientific Corporation
    • 15.3.8. Cochlear Ltd.
    • 15.3.9. Conmed Corporation
    • 15.3.10. Definitive Healthcare, LLC
    • 15.3.11. Demant A/S
    • 15.3.12. Dentsply Sirona Inc.
    • 15.3.13. Edwards Lifesciences Corporation
    • 15.3.14. Globus Medical, Inc.
    • 15.3.15. Integra Lifesciences Holdings Corporation
    • 15.3.16. Invibio Ltd.
    • 15.3.17. Johnson & Johnson Services, Inc.
    • 15.3.18. Koninklijke Philips N.V.
    • 15.3.19. LivaNova plc
    • 15.3.20. Medtronic PLC
    • 15.3.21. Microport Scientific Corporation
    • 15.3.22. NuVasive, Inc.
    • 15.3.23. Smith & Nephew PLC
    • 15.3.24. Sonova Holding AG
    • 15.3.25. Sterling Medical Devices
    • 15.3.26. Straumann AG
    • 15.3.27. Stryker Corporation
    • 15.3.28. Terumo Corporation
    • 15.3.29. W. L. Gore & Associates, Inc.
    • 15.3.30. Zhejiang Nuoerkang Neuroelectronic Technology Co., Ltd.
    • 15.3.31. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY MATERIAL, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. IMPLANTABLE MEDICAL DEVICE MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. IMPLANTABLE MEDICAL DEVICE MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. IMPLANTABLE MEDICAL DEVICE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CARDIAC IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CARDIAC IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CARDIAC IMPLANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CARDIAC IMPLANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CARDIAC IMPLANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CARDIAC IMPLANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CARDIAC IMPLANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CARDIAC IMPLANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY DEFIBRILLATOR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY DEFIBRILLATOR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY DEFIBRILLATOR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY DEFIBRILLATOR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY DEFIBRILLATOR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY DEFIBRILLATOR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY PACEMAKER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY PACEMAKER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY PACEMAKER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY PACEMAKER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY PACEMAKER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY PACEMAKER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COSMETIC IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COSMETIC IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COSMETIC IMPLANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COSMETIC IMPLANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COSMETIC IMPLANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COSMETIC IMPLANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COSMETIC IMPLANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COSMETIC IMPLANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY BREAST IMPLANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY BREAST IMPLANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY BREAST IMPLANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY BREAST IMPLANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY BREAST IMPLANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY BREAST IMPLANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY FACIAL IMPLANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY FACIAL IMPLANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY FACIAL IMPLANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY FACIAL IMPLANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY FACIAL IMPLANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY FACIAL IMPLANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY DENTAL IMPLANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY DENTAL IMPLANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY DENTAL IMPLANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY DENTAL IMPLANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY DENTAL IMPLANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY DENTAL IMPLANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY NEURAL IMPLANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY NEURAL IMPLANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY NEURAL IMPLANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY NEURAL IMPLANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY NEURAL IMPLANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY NEURAL IMPLANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY OPHTHALMIC IMPLANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY OPHTHALMIC IMPLANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY OPHTHALMIC IMPLANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY OPHTHALMIC IMPLANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY OPHTHALMIC IMPLANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY OPHTHALMIC IMPLANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY ORTHOPEDIC IMPLANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY ORTHOPEDIC IMPLANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY ORTHOPEDIC IMPLANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY ORTHOPEDIC IMPLANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY ORTHOPEDIC IMPLANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY ORTHOPEDIC IMPLANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY HIP IMPLANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY HIP IMPLANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY HIP IMPLANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY HIP IMPLANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY HIP IMPLANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY HIP IMPLANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY KNEE IMPLANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY KNEE IMPLANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY KNEE IMPLANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY KNEE IMPLANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY KNEE IMPLANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY KNEE IMPLANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CERAMIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CERAMIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CERAMIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CERAMIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CERAMIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CERAMIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY METAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY METAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY METAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY METAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY METAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY METAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY POLYMER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY POLYMER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY POLYMER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY POLYMER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY POLYMER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY POLYMER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CARDIOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COSMETIC PROCEDURES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COSMETIC PROCEDURES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COSMETIC PROCEDURES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COSMETIC PROCEDURES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COSMETIC PROCEDURES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COSMETIC PROCEDURES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY DENTISTRY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY DENTISTRY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY DENTISTRY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY DENTISTRY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY DENTISTRY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY DENTISTRY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY NEUROLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY NEUROLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY NEUROLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY ORTHOPEDICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY ORTHOPEDICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY ORTHOPEDICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY ORTHOPEDICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 159. AMERICAS IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 160. AMERICAS IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 161. AMERICAS IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 162. AMERICAS IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 163. AMERICAS IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CARDIAC IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 164. AMERICAS IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CARDIAC IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 165. AMERICAS IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COSMETIC IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 166. AMERICAS IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COSMETIC IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 167. AMERICAS IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 168. AMERICAS IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 169. AMERICAS IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 170. AMERICAS IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 171. AMERICAS IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 172. AMERICAS IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 173. AMERICAS IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 174. AMERICAS IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 175. NORTH AMERICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. NORTH AMERICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. NORTH AMERICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 178. NORTH AMERICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 179. NORTH AMERICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CARDIAC IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 180. NORTH AMERICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CARDIAC IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 181. NORTH AMERICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COSMETIC IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 182. NORTH AMERICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COSMETIC IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 183. NORTH AMERICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 184. NORTH AMERICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 185. NORTH AMERICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 186. NORTH AMERICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 187. NORTH AMERICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 188. NORTH AMERICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 189. NORTH AMERICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 190. NORTH AMERICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 191. LATIN AMERICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. LATIN AMERICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. LATIN AMERICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 194. LATIN AMERICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 195. LATIN AMERICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CARDIAC IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 196. LATIN AMERICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CARDIAC IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 197. LATIN AMERICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COSMETIC IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 198. LATIN AMERICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COSMETIC IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 199. LATIN AMERICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 200. LATIN AMERICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 201. LATIN AMERICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 202. LATIN AMERICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 203. LATIN AMERICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 204. LATIN AMERICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 205. LATIN AMERICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 206. LATIN AMERICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 209. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 210. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 211. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CARDIAC IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 212. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CARDIAC IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 213. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COSMETIC IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 214. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COSMETIC IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 215. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 217. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 218. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 219. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 222. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 223. EUROPE IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 224. EUROPE IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 225. EUROPE IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 226. EUROPE IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 227. EUROPE IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CARDIAC IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 228. EUROPE IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CARDIAC IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 229. EUROPE IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COSMETIC IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 230. EUROPE IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COSMETIC IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 231. EUROPE IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 232. EUROPE IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 233. EUROPE IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 234. EUROPE IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 235. EUROPE IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 236. EUROPE IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 237. EUROPE IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 238. EUROPE IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 239. MIDDLE EAST IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 240. MIDDLE EAST IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 241. MIDDLE EAST IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 242. MIDDLE EAST IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 243. MIDDLE EAST IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CARDIAC IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 244. MIDDLE EAST IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CARDIAC IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 245. MIDDLE EAST IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COSMETIC IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 246. MIDDLE EAST IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COSMETIC IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 247. MIDDLE EAST IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 248. MIDDLE EAST IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 249. MIDDLE EAST IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 250. MIDDLE EAST IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 251. MIDDLE EAST IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 252. MIDDLE EAST IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 253. MIDDLE EAST IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 254. MIDDLE EAST IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 255. AFRICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 256. AFRICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 257. AFRICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 258. AFRICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 259. AFRICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CARDIAC IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 260. AFRICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CARDIAC IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 261. AFRICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COSMETIC IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 262. AFRICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COSMETIC IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 263. AFRICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 264. AFRICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 265. AFRICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 266. AFRICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 267. AFRICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 268. AFRICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 269. AFRICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 270. AFRICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 271. ASIA-PACIFIC IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 272. ASIA-PACIFIC IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 273. ASIA-PACIFIC IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 274. ASIA-PACIFIC IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 275. ASIA-PACIFIC IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CARDIAC IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 276. ASIA-PACIFIC IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CARDIAC IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 277. ASIA-PACIFIC IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COSMETIC IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 278. ASIA-PACIFIC IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COSMETIC IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 279. ASIA-PACIFIC IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 280. ASIA-PACIFIC IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 281. ASIA-PACIFIC IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 282. ASIA-PACIFIC IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 283. ASIA-PACIFIC IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 284. ASIA-PACIFIC IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 285. ASIA-PACIFIC IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 286. ASIA-PACIFIC IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 287. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 288. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 289. ASEAN IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 290. ASEAN IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 291. ASEAN IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 292. ASEAN IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 293. ASEAN IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CARDIAC IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 294. ASEAN IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CARDIAC IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 295. ASEAN IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COSMETIC IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 296. ASEAN IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COSMETIC IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 297. ASEAN IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 298. ASEAN IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 299. ASEAN IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 300. ASEAN IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 301. ASEAN IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 302. ASEAN IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 303. ASEAN IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 304. ASEAN IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 305. GCC IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 306. GCC IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 307. GCC IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 308. GCC IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 309. GCC IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY C